A randomised open-label study comparing the safety and efficacy of two alternative treatment options in the management of HIV-1 infected participants who have virologically failed a standard first-line combination ART regimen

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

For the past decade there has been an unprecedented international effort to provide access to care for all HIV-infected people as a basic human right. Most of these people are treated with a simple combination of drugs that are well proven to control HIV. However, what to do when this first drug combination stops working is unknown. This study aims to fill that knowledge gap so that patients failing the first drug combination can be offered a second combination with a maximal chance of success.

Funded Activity Details

Start Date: 01-01-2013

End Date: 01-01-2013

Funding Scheme: Project Grants

Funding Amount: $457,676.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Infectious Diseases

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

antiretroviral therapy | clinical research | efficacy | evidence-based clinical practice | human immunodeficiency virus (HIV) | safety | toxicity